Biosimilar Newsletter Archive

11. 05.11.25 -- Embracing Outsourcing Quality Management In BioPharm 5/11/2025
    05/11/25 Biosimilar Development Newsletter
12. 05.08.25 -- Embracing Outsourcing Quality Management In BioPharm 5/8/2025
    05/08/25 Biosimilar Development Newsletter
13. 05.01.25 -- 3 Strategies For mAb Manufacturing: How Do You Choose? 5/1/2025
    05/01/25 Biosimilar Development Newsletter
14. 04.24.25 -- Intensifying Downstream Processing With Magnetic Separation 4/24/2025
    04/24/25 Biosimilar Development Newsletter
15. 04.17.25 -- AI Performance Management In Biologic And Drug Development 4/17/2025
    04/17/25 Biosimilar Development Newsletter
16. 04.10.25 -- U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance 4/10/2025
    04/10/25 Biosimilar Development Newsletter
17. 04.03.25 -- Optimize Downstream Separation With Tagless Proteins 4/3/2025
    04/03/25 Biosimilar Development Newsletter
18. 03.27.25 -- Challenges & Opportunities Of Outsourcing Biopharma Development 3/27/2025
    03/27/25 Biosimilar Development Newsletter
19. 03.26.25 -- De-Risk The Transfer of Process and Product Knowledge With an Experienced CDMO 3/26/2025

    03/26/25 Biosimilar Development Newsletter

20. 03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture 3/20/2025
    03/20/25 Biosimilar Development Newsletter